Women often face delays, dismissal of symptoms, and lower participation in clinical trials. Socioeconomic status, race, and geographic location contribute to increasing disparities. Gender-responsive policies, inclusive research, and equitable access to care are critical for addressing these gaps. Advocacy and education are driving policy changes.